Main countries for biopharmaceutical imports South Korea 2019, by import value
In 2019, the United States were the leading country of origin for biopharmaceuticals imported into South Korea, with an import value of around 382.6 million U.S. dollars. This was followed by Switzerland and the UK. The majority of import partners in the biopharmaceutical industry were European countries.
